TCM
STIM icon

Timpani Capital Management’s Neuronetics STIM Stock Holding History

Timpani Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,581
Closed -$371K – 103
2018
Q3 		$371K Sell
11,581
-814
-7% -$24.7K 0.11% 97
2018
Q2 		$330K Buy
+12,395
New +$337K 0.1% 92

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Timpani Capital Management's STIM Position: Q4 2018 in Review

Timpani Capital Management sold out of Neuronetics (STIM) in Q4 2018, closing a stake of 11,581 shares — an estimated $371K sold.

Timpani Capital Management first reported a position in STIM in Q2 2018 and held it in 2 quarters. The position peaked at $371K in Q3 2018. 62 funds tracked by Wall St. Rank hold STIM as of Q4 2018.

  • Timpani Capital Management reported no remaining Neuronetics position as of Q4 2018 after selling out during the quarter.
  • Timpani Capital Management sold 11,581 Neuronetics shares in Q4 2018, an estimated $371K.
  • Timpani Capital Management first reported a position in Neuronetics in Q2 2018 and held it in 2 quarters.
  • Timpani Capital Management's Neuronetics position peaked at $371K in Q3 2018.
  • 62 funds tracked by Wall St. Rank held Neuronetics as of Q4 2018.

Based on Timpani Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.